Od-034911 MH CPGs for Treatment of Women with Hypertensive Disorders in Pregnancy & Magnesium Sulfate for Preeclampsia/Eclampsia
Enroll
| MedStar Health CPGs for Treatment of Women with Hypertensive Disorders in Pregnancy & Magnesium Sulfate for Preeclampsia/Eclampsia |
| Title |
|---|
|
MSH CPGs for Treatment of Hypertensive Disorders in Pregnancy/Magnesium Sulfate for Preeclampsia/Eclampsia CE Info show details
MSH CPGs for Treatment of Hypertensive Disorders in Pregnancy/Magnesium Sulfate for Preeclampsia/Eclampsia CE Info
|
|
MedStar Health CPGs for Treatment of Women with Hypertensive Disorders in Pregnancy & Magnesium Sulfate for Preeclampsia/Eclampsia show details
Hypertensive disorders of pregnancy, including preeclampsia, are a leading cause of maternal and infant deaths in the United States. Prompt recognition, management, and treatment of severe hypertension and preeclampsia reduces morbidity and mortality. The MedStar Health Clinical Practice Guideline for Treatment of Women with Hypertensive Disorders in Pregnancy and Clinical Practice Guideline for Magnesium Sulfate for Pre-Eclampsia and Eclampsia provide evidence-based guidance on recognition, treatment, and management of these conditions for providers, midwives, and nursing staff.
|